Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
GILEAD SCIENCES (NZ),Bictegravir 50 mg / Emtricitabine 200 mg / Tenofovir alafenamide 25 mg,HIV-1 infection in adults,Bictegravir 50 mg / Emtricitabine 200 mg / Tenofovir alafenamide 25 mg (BIKTARVYÂ® tablets),Only if cost neutral or cost saving,Community and Hospital,Infections - Agents for Systemic Use
